First trimester screening of serum advanced glycation end products levels of pregnant women who have risk factors for gestational diabetes and their obstetric outcomes: a preliminary case-control study.

Gurbuz, Ozge; Yorganci, Ayçag; Ozgu-Erdinc, A Seval; Tasci, Yasemin

Gurbuz, Ozge; Yorganci, Ayçag; Ozgu-Erdinc, A Seval; Tasci, Yasemin.

Afiliação

Gurbuz O; Clinics of Obstetrics and Gynecology, Ministry of Health, Gaziantep Sehitkamil State Hospital, Gaziantep, Turkey.
Yorganci A; Department of Obstetrics and Gynecology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Ozgu-Erdinc AS; Department of Obstetrics and Gynecology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Tasci Y; School of Medicine, Department of Obstetrics and Gynecology, Kütahya Health Sciences University, Kütahya, Turkey.

J Obstet Gynaecol ; 42(7): 3048-3054, 2022 Oct.

Article em En | MEDLINE | ID: mdl-35653797

Assuntos

Diabetes Gestacional; Recém-Nascido; Gravidez; Feminino; Humanos; Primeiro Trimestre da Gravidez; Gestantes; Estudos de Casos e Controles; Resultado da Gravidez; Fatores de Risco; Produtos Finais de Glicação Avançada

Palavras-chave

Advanced glycation end-products; adverse prenatal outcome; first-trimester; gestational diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google